MPNs including polycythemia vera (PV), essential thrombocythemia (ET), and MF are characterized by overactive Jak/Stat pathway signaling, usually resulting from mutations in JAK2, MPL, or CALR. This evidence concerns the gene SOAT1 and essential thrombocythemia.